European Commission HORIZON-INFRA-2021-EMERGENCY FUNDING
As first emergency funding under Horizon Europe the European Commission is mobilising €123 million from Horizon Europe for urgent research into coronavirus variants. New calls have been launched that will complement earlier actions for development of treatments and vaccines, and contribute to the Commission’s overall action to prevent, mitigate and respond to the impact of coronavirus variants.
Projects under the new calls are expected to:
- Establish new and/or build on existing large-scale, multi-centre and regional or multinational cohorts, including beyond Europe’s borders, which should rapidly advance the knowledge on SARS-CoV-2 and its emerging variants.
- Further develop promising therapeutic or vaccine candidates against SARS-CoV-2/COVID-19, having already completed preclinical development in clinical studies.
- Support research infrastructures to speed up data sharing and deliver fast research support and expertise, to confront the coronavirus variants and to be ready for future epidemics
Open Emergency Calls
1. FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases (RIA)
This action aims to enable researchers, health care professionals and society at large to share, access, analyse, link and process research data and other research digital objects across disciplines and national borders in response to the COVID-19 pandemic.
Scope: Proposals should facilitate and accelerate the access to, and the linking of data and metadata on SARS-CoV-2 and COVID-19, including through the European COVID-19 Data Portal, the Versatile Emerging infectious disease Observatory (VEO) and other relevant initiatives, with the emphasis on identifying and tracking of new SARS-CoV-2 variants and creating appropriate links with serology and other host data.
2. Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics (RIA)
Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics (RIA) aims to integrate research infrastructure services to form a comprehensive and inclusive portfolio to support research in response to infectious disease epidemics or underpinning respective forefront research in the field.
Scope: Proposals will support the provision of trans-national and/or virtual access to researchers as well as training for using the infrastructures, and activities to improve, customise and integrate the services the infrastructures provide, so as to facilitate and integrate the access procedures and to further develop the remote or virtual provision of services.
3. Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment (RIA)
Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment (RIA) aims at supporting activities that enable the conduct of vaccine & therapeutic trials to boost prevention and further inform public health policy and clinical management.
Scope: Proposals submitted under this expression of interest should aim to further develop promising therapeutic or prophylactic candidates against SARS-CoV-2/COVID-19.
4. Cohorts united against COVID-19 variants of concern (RIA)
Cohorts united against COVID-19 variants of concern (RIA) aims at supporting activities that are enabling or contributing to the development of large scale, COVID-19 cohorts and networks worldwide, including beyond Europe’s borders, forging links with European initiatives as a global response to the pandemic.
Scope: Proposals submitted under this expression of interest are expected to build on existing large-scale, multi-centre, regional or international cohorts worldwide and/or establish new ones linked to those.